Vol. 23 No. 1 Jan.-Apr. 2006


Table of Contents

ORIGINAL ARTICLES
21-24

In Vitro Activity of Colistin and Tigecycline Against Extended-Spectrum-Beta-Lactamase (ESBL)-Producing Escherichia coliand Klebsiella pneumoniaeIsolated from Patients in Siriraj Hospital
Pattarachai Kiratisin M.D., M.Sc., Ph.D., Surapee Tiengrim M.Sc., Thitiya Yungyuen M.Sc., Visanu Thamlikitkul M.D.

Full Text 19.79 KB

colistin, tigecycline, ESBL, Escherichia coli, Klebsiella pneumoniae

 

15-19

Emergence of Multidrug-Resistant Shigellain Iran
Ahmad Khorshidi Ph.D, Hossein Akbari M.Sc.

Full Text 25.62 KB

multidrug resistance, Shigella, acute diarrhea

 

9-14

In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of ExtendedSpectrum-β-lactamase-ProducingKlebsiella pneumoniae and Escherichia coli
Ratri Hortiwakul M.Sc., Pantip Chayakul M.D., Natnicha Ingviya B.Sc.

Full Text 29.88 KB

Extended-spectrum β-lactamase, ESBL-producingKlebsiella pneumoniae, ESBL-producingEscherichia coli, cefminox, cefepime, imipenem, meropenem

 

5-8

Clinical Characteristics and Epidemiology of Tetanus at Burirum Hospital
Pawinee Wongprasit , Somnuek Sungkanuparph M.D.

Full Text 26.60 KB

tetanus, vaccine, Burirum, predictive factor, death

 

1-4

In Vitro Activity of Tigecycline Against MethicillinResistant Staphylococcus aureusIsolated from the Patients at Siriraj Hospital
Suwanna Trakulsomboon Ph.D, Visanu Thamlikitkul M.D.

Full Text 20.36 KB

Tigecycline, Methicillin-Resistant Staphylococcus aureus

 


PHOTO QUIZ
25

A 28-year-old man presented with fever and progressive skin eruptions for 2 weeks.
Piroon Mootsikapun M.D.

Question Answer

 


REVIEW ARTICLE
27-45

Nucleoside Analogues and Mitochondrial Toxicity
Ubonvan Jongwutiwes M.D.

Full Text 89.25 KB

mitochondrial toxicity, NRTIs, nucleoside analogues, HIV, lactic acidosis, peripheral neuropathy, pancreatitis, lipoatrophy

 


INFECTIOUS DISEASE LITERATURE
49-50

Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double Blind, Placebo-Controlled Trial
Anuwat Keerasuntonpong M.D.

Full Text 10.78 KB